About the Journal

Journal of Metabolic Disorders and Diabetes is an international, peer-reviewed, open access journal dedicated to publishing high-quality original research, reviews, clinical studies, and scholarly contributions in the broad fields of metabolic disorders, diabetes, endocrinology, and related biomedical and therapeutic sciences. The journal provides a multidisciplinary platform for scientists, physicians, clinicians, researchers, healthcare professionals, and other experts to disseminate innovative findings, clinical advances, and emerging knowledge that contribute to a better understanding, diagnosis, prevention, and management of metabolic diseases and diabetes.

In an era of rapid advancements in medical research, metabolic science, and precision healthcare, the dissemination of reliable and impactful scientific knowledge has become increasingly important. The Journal of Metabolic Disorders and Diabetes is established with the vision of promoting research excellence and facilitating the global exchange of scientific knowledge, bridging the gap between fundamental discoveries and their translation into effective clinical applications and improved healthcare outcomes.

The journal welcomes significant and innovative contributions that advance knowledge in areas such as the molecular and cellular mechanisms of metabolic diseases, diabetes pathophysiology, obesity, insulin resistance, metabolic syndrome, endocrine disorders, diabetic complications, nutritional metabolism, biomarkers, diagnostic approaches, pharmacological interventions, lifestyle management, and emerging therapeutic strategies.

As an international journal, Journal of Metabolic Disorders and Diabetes welcomes submissions from researchers, clinicians, academic institutions, hospitals, and research organizations worldwide. The journal encourages interdisciplinary collaboration and promotes the exchange of knowledge among professionals working across different areas of metabolic medicine, diabetes research, endocrinology, nutrition, molecular biology, pharmacology, and related disciplines.

The journal is committed to providing equal opportunities for researchers from all regions and backgrounds to share their scientific contributions. By encouraging broad international participation, the journal aims to support diversity, collaboration, and the global advancement of research addressing metabolic disorders and diabetes.

Peer Review Excellence

The journal follows a rigorous double-blind peer review process, ensuring that both authors and reviewers remain anonymous throughout the evaluation process. This approach eliminates bias and guarantees a fair, objective, and transparent review of all submitted manuscripts.

Each submission undergoes a thorough assessment by qualified experts in the relevant field, who evaluate the manuscript based on originality, scientific validity, methodological soundness, and relevance to the journal’s focus. The editorial board carefully considers reviewers’ feedback before making final decisions regarding acceptance, revision, or rejection.

To meet the needs of researchers requiring timely publication, the journal also offers a fast-track review process, enabling rapid evaluation and publication of high-priority manuscripts without compromising the quality of peer review. This feature is particularly beneficial for time-sensitive research findings and emerging scientific developments.

Open Access Policy and Creative Commons Licensing

Journal of Metabolic Disorders and Diabetes operates under a full open access publishing model, ensuring that all articles are freely accessible to readers worldwide without subscription barriers. This approach enhances the dissemination and impact of research, allowing knowledge to reach a broader audience including researchers, clinicians, policymakers, and the general public.

All published articles are distributed under Creative Commons licensing, which permits users to read, download, copy, distribute, and reproduce the content in any medium, provided that appropriate credit is given to the original authors. This policy supports the principles of transparency, accessibility, and knowledge sharing in scientific research.

Open access publishing not only increases the visibility of authors’ work but also contributes to higher citation rates and broader academic recognition.

Digital Identification and Indexing Support

To ensure the long-term accessibility and traceability of published research, the journal assigns a Digital Object Identifier (DOI) to each article through Crossref. This enables accurate citation, easy retrieval, and integration with global research databases.

In addition, all published articles are submitted for indexing in Google Scholar after publication, enhancing discoverability and ensuring that research is accessible to the global academic community. The journal continuously works toward inclusion in additional indexing and abstracting databases to further expand its reach and credibility

Language and Accessibility

The journal publishes all manuscripts in English, the universally accepted language of scientific communication. This ensures clarity, consistency, and accessibility for an international audience.

Authors are encouraged to present their research in a clear and concise manner, enabling readers from diverse academic and professional backgrounds to understand and apply the findings effectively. The journal also supports the use of standardized scientific terminology and formatting to maintain consistency across publications.

Ethical Standards and Integrity

The journal is committed to maintaining the highest standards of publication ethics and academic integrity. All submissions are expected to be original and free from plagiarism, data fabrication, or any form of unethical practice.

Authors are required to disclose any potential conflicts of interest and ensure that their research complies with ethical guidelines, particularly in studies involving human participants or animals. The journal follows internationally recognized ethical standards to safeguard the credibility and reliability of published research.

By enforcing strict ethical policies, the journal ensures trust among authors, reviewers, and readers.

Contribution to Scientific Advancement

The primary goal of the Journal of Metabolic Disorders and Diabetes is to contribute to the advancement of knowledge in metabolic health, diabetes, endocrinology, and related areas of biomedical and clinical research. Through the publication of high-quality scientific work, the journal aims to support the development of new knowledge and encourage collaboration among researchers and healthcare professionals.

The journal welcomes interdisciplinary research spanning diverse fields, including molecular medicine, genetics, genomics, nutrition, obesity and metabolic health, endocrinology, pharmacology, public health, clinical medicine, and translational research.

Through its commitment to scientific excellence, open accessibility, ethical publishing, and international collaboration, the Journal of Metabolic Disorders and Diabetes aims to serve as a valuable platform for advancing research and improving understanding of metabolic diseases and diabetes.

By fostering innovation and ensuring the widespread availability of research findings, the journal strives to contribute to improved prevention, diagnosis, treatment, and management of metabolic disorders and diabetes, ultimately supporting better health outcomes and well-being worldwide.